Diabetes-Metabolism Research and Reviews

Papers
(The H4-Index of Diabetes-Metabolism Research and Reviews is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
378
Cover Image213
Issue Information178
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis121
The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application95
Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials89
Central and Peripheral Sensitivity to Thyroid Hormones Correlate to Metabolically Obesity Phenotypes in Chinese Euthyroid Adults: A Cross‐Sectional Study89
Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort65
Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 203562
Longitudinal cardiovascular health measured by life's essential 8 metrics with incident diabetes: A 13‐year prospective cohort study58
Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking54
Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)53
The circadian syndrome is a predictor for cognition impairment in middle‐aged adults: Comparison with the metabolic syndrome51
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors50
46
Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China45
Withdrawal: Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquill44
A variation in SORBS1 is associated with type 2 diabetes and high‐density lipoprotein cholesterol in Chinese population43
Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes42
Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes41
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials34
The relationship between neonatal hypoglycaemia and cord blood C‐peptide levels in neonates of birthing individuals with type 1 diabetes32
Classification of foot ulcers in people with diabetes: A systematic review32
Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes31
30
Stuttering in adolescence and the risk for dysglycemia in early adulthood30
SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all‐cause mortality, in Caucasians with type 2 diabetes: A 13‐year observational study29
Issue Information29
Reduced early response to SARS‐CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow‐up study: The CoVaDiab study I28
Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabet28
0.055341005325317